In brief: F&P boosts profits, ResMed launches in Japan

Tuesday, May 29, 2012

AUCKLAND, New Zealand – Fisher & Paykel Healthcare says expanding clinical applications for its medical devices and new products contributed to record operating revenue of NZ$516.7 million for the year ended March 31, 2012. The company reported net profit after tax of NZ$64.1 million for the year ended March 31, 2012, compared to NZ$52.5 million for the prior year. Excluding deferred tax charges of NZ$11.5 million in 2011, F&P Healthcare’s net profit after tax grew 23%, primarily due to revenue growth, disciplined control of expenses and other efficiencies, according to a statement. Operating revenue for its respiratory and acute care product group increased by 18% in U.S. dollars for the year ended March 31, 2012, compared to the prior year, and its obstructive sleep apnea product group increased by 7% over the same time period. "We expect our underlying revenue growth to begin to accelerate this year, particularly in the second half, as a number of new products, including new OSA masks, are introduced around the world,” stated Michael Daniell, CEO of F&P Healthcare, in a release.

ResMed launches in Japan

SAN DIEGO – ResMed has launched a new wireless sleep-monitoring device in Japan using technology from BiancaMed, which it recently acquired, and in partnership with Omron Healthcare. Users place Omron Sleep Design HSL-101 by their beds at night to measure their sleep and to log key sleep quality metrics like sleep onset time and total sleep time. When users report data through Omron’s Wellness Link service, they get “a full picture of sleep health,” alongside customized summaries, health tips and advice. “We believe that by monitoring sleep and encouraging sleep health, the Sleep Design HSL-101 and support services provide a convenient tool for early prevention and intervention,” stated Dr. Conor Handley, managing director of the BiancaMed division at ResMed, in a release. The device is part of Omron Healthcare’s “All for Healthcare” strategy to develop health monitoring products and health support services for the home.